Multimodal Functional Imaging for Early Response Assessment in GIST Patients Treated With Imatinib

Acta Oncol. 2014 Jan;53(1):143-8. doi: 10.3109/0284186X.2013.798428. Epub 2013 May 28.

Abstract

No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Aged
  • Aged, 80 and over
  • Antineoplastic Agents / therapeutic use*
  • Benzamides / therapeutic use*
  • Feasibility Studies
  • Female
  • Fluorodeoxyglucose F18
  • Follow-Up Studies
  • Gastrointestinal Stromal Tumors / drug therapy*
  • Gastrointestinal Stromal Tumors / pathology
  • Gastrointestinal Stromal Tumors / secondary*
  • Humans
  • Imatinib Mesylate
  • Magnetic Resonance Imaging
  • Male
  • Middle Aged
  • Multimodal Imaging*
  • Neoplasm Metastasis
  • Neoplasm Staging
  • Piperazines / therapeutic use*
  • Positron-Emission Tomography
  • Pyrimidines / therapeutic use*
  • Radiopharmaceuticals
  • Tomography, X-Ray Computed
  • Treatment Outcome

Substances

  • Antineoplastic Agents
  • Benzamides
  • Piperazines
  • Pyrimidines
  • Radiopharmaceuticals
  • Fluorodeoxyglucose F18
  • Imatinib Mesylate

Associated data

  • ClinicalTrials.gov/NCT01276483